Form D · Other
Universal Ibogaine Inc.
Vancouver, A1 · CIK 0001774925
Offering snapshot reported Nov 20, 2020 · SEC filing
- Reported sold
- $48.2K Offering amount: $48.2K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 9, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 20, 2020 | Initial | $48,188 | No comparison | 1 | SEC filing |
| Oct 29, 2020 | Initial | $75,920 | No comparison | 2 | SEC filing |
| Apr 26, 2019 | Initial | $11,253 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-381222
EXCHANGE RATE $1 CAD = $0.7710 USD
Source: Form D, filed Nov 20, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alberto Sola Agullo | Director, Executive |
| Ian Campbell | Director |
| Patrick Kroupa | Director |
| Shayne Nyquvest | Director, Executive |
| Robert Turner | Director |
| Jeremy Weate | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
595 Howe Street Suite 303
Vancouver, A1, V6C 2T5
Vancouver, A1, V6C 2T5